StockWatch
·
Biotechnology: Pharmaceutical Preparations
MergerJul 17, 2026, 04:32 PM

Inflection Point Amends GOWell Merger Terms; Increases Expense Cap

AI Summary

Inflection Point Acquisition Corp. V (IPEX) and GOWell Technology Limited amended their Business Combination Agreement. The amendment introduces a new partial earnout tier for 2026 EBITDA at 80% achievement, mirroring the 2027 and 2028 earnout structures. Additionally, the cap on SPAC Transaction Expenses was raised from $8 million to $9 million, with certain specified expenses excluded from this cap.

Key Highlights

  • Amended Business Combination Agreement with GOWell Technology Limited.
  • Introduced new partial earnout tier for 2026 EBITDA at 80% achievement for 2,890,000 Earnout Shares.
  • Existing 2026 EBITDA earnout tiers remain at 90% (3,330,000 shares) and 100% (5,000,000 shares).
  • Increased SPAC Transaction Expenses cap from $8,000,000 to $9,000,000.
  • Excluded certain expenses, including deferred underwriting commissions and specific advisory fees (up to $2,000,000), from the cap.